192 results on '"Scott-Algara, D"'
Search Results
2. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN
3. S100A9 protein is a novel ligand for the receptor CD85j and their interaction is implicated in the NK cell-mediated control of HIV-1 replication
4. OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro
5. Cryptococcose neuroméningée chez un sujet en apparence immunocompétent
6. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
7. Partial Restoration of Cytokine Profile Despite Reconstitution of Cytomegalovirus-Specific Cell-Mediated Immunity in Human Immunodeficiency Virus-Infected Patients During Highly Active Antiretroviral Treatment
8. Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse model
9. CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART
10. Immune-phenotypic characteristics associated with an effective acute-phase response predict a reduced amount of integrated HIV DNA in naïve CD4+ T-cells in patients treated during acute HIV infection
11. Preservation of IL-17 producing γδ T cells and their role in the control of immune activation in HIV controllers: ANRS EP56 study
12. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement
13. The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism
14. Phenotypic and functional features of African green monkey monocyte-derived dendritic cells
15. Assessment of function of myeloid dendritic cells derived from African green monkey blood monocytes
16. Generation of semi-mature myeloid dendritic cells derived from African green monkey blood monocytes
17. Phenotype Alterations in Regulatory T-Cell Subsets in Primary HIV Infection and Identification of Tr1-like Cells as the Main Interleukin 10-Producing CD4+ T Cells
18. Immunological and Antiviral Responses After Therapeutic DNA Immunization in Chronic Hepatitis B Patients Efficiently Treated by Analogues
19. Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN
20. Naive T Lymphocytes and Recent Thymic Emigrants Are Associated With HIV-1 Disease History in French Adolescents and Young Adults Infected in the Perinatal Period: The ANRS-EP38-IMMIP Study
21. The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection
22. 1367 RELAPSE AFTER ANALOGUES TREATMENT DISCONTINUATION IS NOT PREVENTED BY DNA VACCINATION IN CHRONIC HEPATITIS B (ANRS HB 02 VAC-ADN)
23. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients
24. Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carriers and AIDS patients
25. ANTI-INFLAMMATORY AND ANTI-ATHEROGENIC EFFECTS OF THE NF-KAPPAB INHIBITOR ACETYL-11-KETO-BETA-BOSWELLIC ACID IN LPS-CHALLENGED APOE-/- MICE
26. O.098 Changes in NK cell repertoire after therapeutic HBV vaccination could be correlated to induction of HBV-specific T-cell responses
27. CA10 - Induction d’une réponse cellulaire T spécifique anti-hbs chez des malades ayant une hépatite B chronique au cours d’un traitement par vaccination ADN
28. 437 Induction of HBS-specific T cell responses in HBV chronic carriers by an hepatitis B virus DNA vaccine
29. NK Cells and HIV Infection: Lessons from other Viruses
30. Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen.
31. In vitro non-productive infection of purified natural killer cells by the BRU isolate of the human immunodeficiency virus type 1
32. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored afterin vitrolong-term culture of NK cells
33. Evaluation of serum levels of tumour necrosis factor-alpha (TNF-α) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment
34. Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients
35. T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination
36. Serum Levels of IL-2, IL-1α, TNF-α, and Soluble Receptor of IL-2 in HIV-1-Infected Patients
37. The frequency of HIV-specific interferon-gamma-producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.
38. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.
39. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
40. SUPPRESSION OF THE IN VITRO PARENT ANTIHYBRID REACTION BY SPLEEN CELLS FROM F1 HYBRIDS PRETREATED WITH SPLEEN CELLS FROM THE OPPOSITE PARENT STRAIN.
41. SPECIFIC AND NONSPECIFIC RESISTANCE TO LOCAL GRAFT-VERSUS-HOST REACTION IN F1 HYBRIDS PRETREATED INTRAVENOUSLY WITH PARENT-STRAIN SPLEEN CELLS.
42. Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carriers and AIDS patients.
43. SUPPRESSION OF THE IN VITRO PARENT ANTIHYBRID REACTION BY SPLEEN CELLS FROM F1HYBRIDS PRETREATED WITH SPLEEN CELLS FROM THE OPPOSITE PARENT STRAIN
44. SPECIFIC AND NONSPECIFIC RESISTANCE TO LOCAL GRAFTVERSUSHOST REACTION IN F1HYBRIDS PRETREATED INTRAVENOUSLY WITH PARENTSTRAIN SPLEEN CELLS
45. In vivo Adriamycin-induced apoptosis in peritoneal murine macrophages: Partial participation of a caspase cascade
46. γ-irradiation induced apoptosis in peritoneal macrophages by oxidative stress. Implications of antioxidants in caspase mitochondrial pathway
47. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
48. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. III. Study of the mechanism.
49. SUPPRESSION OF THE IN VITRO PARENT ANTIHYBRID REACTION BY SPLEEN CELLS FROM F1 HYBRIDS PRETREATED WITH SPLEEN CELLS FROM THE OPPOSITE PARENT STRAIN
50. SPECIFIC AND NONSPECIFIC RESISTANCE TO LOCAL GRAFT-VERSUS-HOST REACTION IN F1 HYBRIDS PRETREATED INTRAVENOUSLY WITH PARENT-STRAIN SPLEEN CELLS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.